Novo CEO pressed by Senate to chop rates of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporation would look at new talks with insurers concerning the list prices of Wegovy and copyright should they pledge to maintain the medicines on their formularies. Investment in electronic https://martinxofvl.estate-blog.com/30073180/5-simple-techniques-for-healthcare-news